Leap Therapeutics Stock Market Value
| LPTX Stock | USD 2.55 0.03 1.16% |
| Symbol | Leap |
Leap Therapeutics Price To Book Ratio
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Leap Therapeutics. If investors know Leap will grow in the future, the company's valuation will be higher. The financial industry is built on trying to define current growth potential and future valuation accurately. All the valuation information about Leap Therapeutics listed above have to be considered, but the key to understanding future value is determining which factors weigh more heavily than others.
Earnings Share (1.64) | Revenue Per Share 0.003 | Return On Assets (0.46) | Return On Equity (0.81) |
The market value of Leap Therapeutics is measured differently than its book value, which is the value of Leap that is recorded on the company's balance sheet. Investors also form their own opinion of Leap Therapeutics' value that differs from its market value or its book value, called intrinsic value, which is Leap Therapeutics' true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Leap Therapeutics' market value can be influenced by many factors that don't directly affect Leap Therapeutics' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Leap Therapeutics' value and its price as these two are different measures arrived at by different means. Investors typically determine if Leap Therapeutics is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Leap Therapeutics' price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Leap Therapeutics 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Leap Therapeutics' stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Leap Therapeutics.
| 12/03/2022 |
| 11/22/2024 |
If you would invest 0.00 in Leap Therapeutics on December 3, 2022 and sell it all today you would earn a total of 0.00 from holding Leap Therapeutics or generate 0.0% return on investment in Leap Therapeutics over 720 days. Leap Therapeutics is related to or competes with X4 Pharmaceuticals, Terns Pharmaceuticals, Day One, PDS Biotechnology, Inozyme Pharma, Elevation Oncology, and Mereo BioPharma. Leap Therapeutics, Inc., a biopharmaceutical company, acquires and develops therapies for the treatment of cancer More
Leap Therapeutics Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Leap Therapeutics' stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Leap Therapeutics upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.02) | |||
| Maximum Drawdown | 25.59 | |||
| Value At Risk | (7.03) | |||
| Potential Upside | 11.08 |
Leap Therapeutics Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Leap Therapeutics' investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Leap Therapeutics' standard deviation. In reality, there are many statistical measures that can use Leap Therapeutics historical prices to predict the future Leap Therapeutics' volatility.| Risk Adjusted Performance | 0.0079 | |||
| Jensen Alpha | (0.12) | |||
| Total Risk Alpha | (0.69) | |||
| Treynor Ratio | (0.01) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Leap Therapeutics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Leap Therapeutics Backtested Returns
Leap Therapeutics has Sharpe Ratio of -0.0024, which conveys that the firm had a -0.0024% return per unit of risk over the last 3 months. Leap Therapeutics exposes twenty-two different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please verify Leap Therapeutics' Risk Adjusted Performance of 0.0079, standard deviation of 5.21, and Mean Deviation of 3.76 to check out the risk estimate we provide. The company secures a Beta (Market Risk) of 1.05, which conveys a somewhat significant risk relative to the market. Leap Therapeutics returns are very sensitive to returns on the market. As the market goes up or down, Leap Therapeutics is expected to follow. At this point, Leap Therapeutics has a negative expected return of -0.0127%. Please make sure to verify Leap Therapeutics' total risk alpha, as well as the relationship between the accumulation distribution and period momentum indicator , to decide if Leap Therapeutics performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.14 |
Insignificant predictability
Leap Therapeutics has insignificant predictability. Overlapping area represents the amount of predictability between Leap Therapeutics time series from 3rd of December 2022 to 28th of November 2023 and 28th of November 2023 to 22nd of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Leap Therapeutics price movement. The serial correlation of 0.14 indicates that less than 14.0% of current Leap Therapeutics price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.14 | |
| Spearman Rank Test | 0.18 | |
| Residual Average | 0.0 | |
| Price Variance | 0.31 |
Leap Therapeutics lagged returns against current returns
Autocorrelation, which is Leap Therapeutics stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Leap Therapeutics' stock expected returns. We can calculate the autocorrelation of Leap Therapeutics returns to help us make a trade decision. For example, suppose you find that Leap Therapeutics has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Leap Therapeutics regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Leap Therapeutics stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Leap Therapeutics stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Leap Therapeutics stock over time.
Current vs Lagged Prices |
| Timeline |
Leap Therapeutics Lagged Returns
When evaluating Leap Therapeutics' market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Leap Therapeutics stock have on its future price. Leap Therapeutics autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Leap Therapeutics autocorrelation shows the relationship between Leap Therapeutics stock current value and its past values and can show if there is a momentum factor associated with investing in Leap Therapeutics.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Leap Stock Analysis
When running Leap Therapeutics' price analysis, check to measure Leap Therapeutics' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Leap Therapeutics is operating at the current time. Most of Leap Therapeutics' value examination focuses on studying past and present price action to predict the probability of Leap Therapeutics' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Leap Therapeutics' price. Additionally, you may evaluate how the addition of Leap Therapeutics to your portfolios can decrease your overall portfolio volatility.